18F-FDG PET/CT of Cervical Carcinoma

被引：30
|
作者：
Patel, Chirag N. [1 ]
Nazir, Sarfraz A. [2 ]
Khan, Zubair [2 ]
Gleeson, Fergus V. [2 ]
Bradley, Kevin M. [2 ]
机构：
[1] St James Univ Hosp, Dept Nucl Med, Leeds LS9 7TF, W Yorkshire, England
[2] Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2011年 / 196卷 / 05期
关键词：
cervical carcinoma; FIGO; PET/CT; response assessment; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE METASTASES; CANCER; FLUORODEOXYGLUCOSE; BIOMARKER;
D O I：
10.2214/AJR.10.5084
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence. CONCLUSION. There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma-in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.
引用
收藏
页码：1225 / 1233
页数：9
相关论文
共 50 条
  • [41] 18F-FDG PET/CT in management of cervical carcinoma - A 5 year experience of an Oncology Center
    Gouveia, P.
    Pinto, A. S.
    Teixeira, R.
    Violante, L.
    Duarte, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S479 - S479
  • [42] Comparison of 18F-FDG PET/CT and 18F-FDG PET/MRI in Detection of Liver Lesions in Hepatocellular Carcinoma for Staging and Restaging
    Demir, B.
    Soydal, C.
    Dursun, E.
    Araz, M.
    Oz, D. Kuru
    Kucuk, N. O.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S71 - S71
  • [43] MRI and 18F-FDG PET/CT interrelationship in the postradiotherapy cervical carcinoma early response assessment
    Lucic, S.
    Spirovski, M.
    Licina, J.
    Stojanovic, D.
    Peter, A.
    Lucic, M. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S555 - S555
  • [44] 18F-FDG PET/MRI versus 18F-FDG PET/CT for the diagnosis of pituitary adenoma
    Wang, Hao
    Zhao, Xiaobin
    Zang, Jie
    Zhu, Zhaohui
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [45] 18F-FDG PET/CT in locally advanced cervical cancer: A review
    Caresia-Aroztegui, A. P.
    Delgado-Bolton, R. C.
    Alvarez-Ruiz, S.
    Del Puig Cozar-Santiago, M.
    Orcajo-Rincon, J.
    de Arcocha-Torres, M.
    Garcia-Velloso, M. J.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 59 - 68
  • [46] The role of 18F-FDG PET/CT in the detection of recurrent cervical cancer
    Escabias del Pozo, C.
    Rodado Marina, S.
    Coronado Poggio, M.
    Santos Gomez, I.
    Marin Ferrer, M.
    Hernandez Martinez, A. C.
    Mendez Mareque, D.
    Coya Vina, J.
    Martin-Curto, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S429 - S429
  • [47] Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma
    Cohade, C
    Osman, M
    Leal, J
    Wahl, RL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (11) : 1797 - 1803
  • [48] CT and 18F-FDG PET/CT in staging or restaging of renal cell carcinoma
    Ozkan, Elgin
    Araz, Mine
    Soydal, Cigdem
    Filik, Mustafa
    Aras, Gulseren
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [49] Pancreatic sarcomatoid carcinoma: CT, MRI, and 18F-FDG PET/CT features
    Zhao, S.
    Su, W.
    Deng, L.
    Chen, Y.
    Zuo, C.
    Shao, C.
    Ren, F.
    [J]. CLINICAL RADIOLOGY, 2020, 75 (05) : 397.e7 - 397.e14
  • [50] Prognostic value of pretherapeutic 18F-FDG PET/CT (PET) and MRI in cervical cancer
    Chastan, Mathieu
    Manrique, Alain
    Baron, Marc
    Diologent, Brigitte
    Edet-Sanson, Agathe
    Guernou, Mohamed
    Modezelewski, Romain
    Vera, Pierre
    Hitzel, Anne
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345